Case Report
Published on 17 Jul 2024
Stiff-person syndrome in association with Hashimoto’s thyroiditis: a case report
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1360222
- 4,460 views
Type at least 3 characters
1,192 articles
articles
Original Research
Published on 16 Jul 2024
Paramagnetic rim lesions as a biomarker to discriminate between multiple sclerosis and cerebral small vessel disease
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1429698
- 4,474 views
- 3 citations
Brief Research Report
Published on 08 Jul 2024
Advancing understanding of the role of IL-22 in myelination: insights from the Cuprizone mouse model
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1411143
- 2,262 views
- 1 citation
Original Research
Published on 03 Jul 2024
Usefulness of bioelectrical impedance analysis in multiple sclerosis patients—the interrelationship to the body mass index
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1409038
- 1,762 views
Review
Published on 03 Jul 2024
The complement system in neurodegenerative and inflammatory diseases of the central nervous system
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1396520
- 11,594 views
- 32 citations
Original Research
Published on 27 Jun 2024
Comparison of injective related reactions following ofatumumab and ocrelizumab in patients with multiple sclerosis: data from the European spontaneous reporting system
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1383910
- 4,461 views
- 6 citations
Original Research
Published on 26 Jun 2024
A comparative study on anti-MOG and anti-AQP4 associated optic neuritis following mild COVID-19: insights from a Chinese single-center experience
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1416493
- 2,445 views
Original Research
Published on 21 Jun 2024
Predictive value of synaptic plasticity for functional decline in patients with multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1410673
- 2,341 views
- 1 citation
Systematic Review
Published on 18 Jun 2024
Disease-modifying therapies and hematological disorders: a systematic review of case reports and case series
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1386527
- 3,887 views
- 1 citation
Original Research
Published on 12 Jun 2024
Abnormal brain spontaneous neural activity in neuromyelitis optica spectrum disorder with neuropathic pain
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1408759
- 2,327 views
- 1 citation
Perspective
Published on 10 Jun 2024
Sex differences in Huntington's disease from a neuroinflammation perspective
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1384480
- 7,432 views
- 10 citations
Original Research
Published on 05 Jun 2024
Leptomeningeal enhancement in multiple sclerosis: a focus on patients treated with hematopoietic stem cell transplantation
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1373385
- 3,419 views
- 2 citations
Case Report
Published on 05 Jun 2024
A case report of AQP4-IgG-seropositive refractory neuromyelitis optica spectrum disorder patient with Sjögren’s syndrome and pancytopenia treated with inebilizumab
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1371515
- 3,159 views
- 1 citation
Original Research
Published on 23 May 2024
Effect of methylphenidate on oculomotor function in individuals with multiple sclerosis: a pilot randomized placebo-controlled trial
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1393877
- 2,562 views
Editorial
Published on 17 May 2024
Editorial: Multiple sclerosis and related disorders: challenges and approaches to mechanisms, biomarkers, and therapeutic targets
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1427299
- 2,082 views
Mini Review
Published on 16 May 2024
Soluble biomarkers for Neuromyelitis Optica Spectrum Disorders: a mini review
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1415535
- 6,619 views
- 17 citations
Review
Published on 09 May 2024
Stem cell therapies: a new era in the treatment of multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1389697
- 20,740 views
- 13 citations
Original Research
Published on 01 May 2024
“A second birthday”? Experiences of persons with multiple sclerosis treated with autologous hematopoietic stem cell transplantation—a qualitative interview study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1384551
- 3,342 views
- 2 citations
Brief Research Report
Published on 01 May 2024
IL-6 receptor antibody treatment improves muscle weakness in experimental autoimmune myasthenia gravis mouse model
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1356300
- 4,430 views
- 9 citations
Original Research
Published on 26 Apr 2024
Patterns of multiple sclerosis presentation to the emergency department
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1395822
- 2,762 views
- 3 citations
Case Report
Published on 23 Apr 2024
Case report: Cerebrospinal fluid neutrophilic pleocytosis upon intrathecal triamcinolone injection
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1372266
- 2,252 views
- 3 citations
Original Research
Published on 19 Apr 2024
Practical tool to identify Spasticity-Plus Syndrome amongst patients with multiple sclerosis. Algorithm development based on a conjoint analysis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1371644
- 2,910 views
- 2 citations
Systematic Review
Published on 18 Apr 2024
Hypogammaglobulinemia and infections in patients with multiple sclerosis treated with anti-CD20 treatments: a systematic review and meta-analysis of 19,139 multiple sclerosis patients
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1380654
- 8,851 views
- 25 citations
Case Report
Published on 18 Apr 2024
Case report: Headache as the sole neurological symptom in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1366263
- 2,835 views